MediWound (MDWD) Revenue Growth (3y) (2017 - 2025)
MediWound (MDWD) Revenue Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | MediWound | 166.33 Mn | 161.53 Mn | 278,000.00 | -45.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.63% |
| Sep 30, 2025 | -2.20% |
| Jun 30, 2025 | 1.67% |
| Mar 31, 2025 | -3.54% |
| Dec 31, 2024 | 2.10% |
| Sep 30, 2024 | 18.10% |
| Jun 30, 2024 | -14.89% |
| Mar 31, 2024 | 25.39% |
| Dec 31, 2023 | -7.17% |
| Sep 30, 2023 | 15.72% |
| Jun 30, 2023 | 5.92% |
| Mar 31, 2023 | -5.05% |
| Dec 31, 2022 | 28.76% |
| Sep 30, 2022 | 4.13% |
| Jun 30, 2022 | 23.09% |
| Mar 31, 2022 | 119.98% |
| Dec 31, 2021 | 76.85% |
| Sep 30, 2021 | 48.16% |
| Jun 30, 2021 | 36.76% |
| Mar 31, 2021 | 69.18% |